IRIS
ZICHE, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.628
EU - Europa 12.364
AS - Asia 6.145
SA - Sud America 1.111
AF - Africa 129
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 36.403
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.484
GB - Regno Unito 3.496
CN - Cina 2.468
RU - Federazione Russa 2.173
SG - Singapore 1.862
IE - Irlanda 1.773
UA - Ucraina 1.237
SE - Svezia 1.034
BR - Brasile 974
DE - Germania 694
IT - Italia 664
FR - Francia 614
HK - Hong Kong 523
KR - Corea 418
FI - Finlandia 377
VN - Vietnam 310
IN - India 204
TR - Turchia 95
CA - Canada 70
ES - Italia 64
AR - Argentina 57
MX - Messico 45
BD - Bangladesh 44
BE - Belgio 43
PL - Polonia 39
ZA - Sudafrica 35
CI - Costa d'Avorio 31
IQ - Iraq 31
NL - Olanda 29
ID - Indonesia 27
JP - Giappone 26
AT - Austria 24
EC - Ecuador 22
PK - Pakistan 19
MA - Marocco 18
AU - Australia 16
VE - Venezuela 16
CO - Colombia 14
LT - Lituania 14
SA - Arabia Saudita 14
KE - Kenya 13
AE - Emirati Arabi Uniti 10
BG - Bulgaria 10
IL - Israele 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
DZ - Algeria 9
RO - Romania 9
JO - Giordania 8
GR - Grecia 7
NP - Nepal 7
PT - Portogallo 7
AM - Armenia 6
BY - Bielorussia 6
CL - Cile 6
DK - Danimarca 6
EE - Estonia 6
EU - Europa 6
PY - Paraguay 6
UY - Uruguay 6
AZ - Azerbaigian 5
CR - Costa Rica 5
OM - Oman 5
PE - Perù 5
PH - Filippine 5
AL - Albania 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
EG - Egitto 4
JM - Giamaica 4
KG - Kirghizistan 4
KH - Cambogia 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
TW - Taiwan 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CY - Cipro 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
IR - Iran 3
LB - Libano 3
MY - Malesia 3
SN - Senegal 3
TT - Trinidad e Tobago 3
CH - Svizzera 2
DM - Dominica 2
GE - Georgia 2
HN - Honduras 2
KW - Kuwait 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
MN - Mongolia 2
RS - Serbia 2
Totale 36.388
Salva come PNG Salva come JPEG
Città #
Southend 3.222
Fairfield 1.981
Dallas 1.885
Dublin 1.756
Ashburn 1.265
Singapore 1.111
Chandler 1.068
Jacksonville 1.007
Woodbridge 939
Houston 887
Seattle 797
Wilmington 782
Cambridge 679
Moscow 585
Beijing 528
Hong Kong 514
Santa Clara 509
Ann Arbor 464
Seoul 417
Hefei 370
Princeton 363
Nanjing 312
Siena 205
Los Angeles 186
The Dalles 177
Boardman 159
San Diego 151
Menlo Park 148
Nanchang 126
Helsinki 124
San Mateo 115
Dong Ket 108
Columbus 103
Fremont 101
Buffalo 100
New York 95
Council Bluffs 92
Pune 85
Tianjin 85
Ho Chi Minh City 78
São Paulo 75
Shenyang 74
Munich 73
Kunming 65
Izmir 63
Bengaluru 55
Hebei 52
Redondo Beach 52
London 46
Changsha 45
Florence 45
Brussels 43
Hanoi 43
Turku 43
Jinan 40
Shanghai 38
Zhengzhou 38
Dearborn 37
Málaga 36
San Francisco 36
Milan 35
Norwalk 35
Warsaw 35
Abidjan 31
Rome 31
Toronto 31
Düsseldorf 30
Jiaxing 30
Atlanta 29
Falls Church 29
Lancaster 29
Brooklyn 27
Chicago 27
Hangzhou 27
Redwood City 27
Nuremberg 26
Guangzhou 24
Tokyo 24
Belo Horizonte 22
Poplar 21
Rio de Janeiro 21
Orem 20
Johannesburg 19
Stockholm 19
Amsterdam 18
Frankfurt am Main 18
Ningbo 18
Phoenix 18
Taizhou 18
Changchun 17
Chennai 17
Boston 16
Denver 15
Jakarta 15
Mexico City 15
Montreal 14
Salvador 14
Brasília 13
Lanzhou 13
Vienna 13
Totale 25.579
Salva come PNG Salva come JPEG
Nome #
Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis 396
Formulation of liposomes functionalized with the Lotus lectin and effective in targeting highly proliferative cells 384
A fucose-containing O-glycoepitope on bovine and human nucleolin 355
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 307
ALDH2 activity reduces mitochondrial oxygen reserve capacity in endothelial cells and induces senescence properties 290
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea 288
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 271
Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells 269
B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects 269
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 269
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels 266
A nanoscale fluorocarbon coating on PET surfaces improves the adhesion and growth of cultured coronary endothelial cells 255
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity 255
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 246
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation. 241
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation 241
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells 240
Angiogenic polypeptides in breast cancer: expression of MRNA’s in primary human tumours, MCF-7 cell transfection and xenograft models 239
The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions 237
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 234
H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall 233
PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells 231
Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1 231
Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability 230
Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin 227
Divergent effects of quercetin conjugates on angiogenesis 226
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing 226
Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response 224
RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation 223
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis 221
Analysis of the role of chemokines in angiogenesis 220
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers 217
Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer 215
Studying vascular angiogenesis and senescence in zebrafish embryos 214
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro 214
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review 212
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 211
Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium. 210
Abolished angiogenicity and tumorigenicity of Burkitt's lymphoma by Interleukin-10 209
Biological characterization of nanocomposite hydrogels 207
VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis 207
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways 204
A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases 204
Absence of PAF actions increases angiogenesis 203
Activity of "NO-donor" or "NO-mediated" drugs 203
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 202
Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells 196
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data 192
Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. 191
Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells 191
Aminoflavone, a ligand of the Aryl Hydrocarbon Receptor (AhR), inhibits HIF-1α expression in an AhR-independent fashion 190
Assessing vascular senescence in zebrafish 190
A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A2 inhibitor, displays antitumour activity 188
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 188
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants 187
Differential contribution of bradykinin receptors in angiogenesis 187
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 187
The rabbit corneal pocket assay 186
An angiogenic role for the neurotrophins midkine and pleiotrophin in tumorigenesis. 185
Role of prostaglandin E1 and copper in angiogenesis 185
A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through a5b1 integrin 184
MPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity 184
ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade 183
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor 180
Derivati 4-sostituiti della 1-(2-cloro-2-feniletil)-1H-pirazolo[3,4-d]pirimidina e loro usi. 179
Activation of MAPK in proximal tubule cells from spontaneously hypertensive and control Wistar-Kyoto rats 177
Nitric oxide synthase lies downstream of vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis 177
PKCε ACTIVATION PROMOTES FGF-2 EXOCYTOSIS AND INDUCES ENDOTHELIAL CELL PROLIFERATION AND SPROUTING 177
Molecular mechanisms of resistance to anti-angiogenic drugs 176
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling 174
Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis 174
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents 174
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 173
The effect of thiorphan on release of sensory neuropeptides from guinea-pig cerebral venous sinuses 173
Role of nitric oxide in the modulation of angiogenesis 171
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivativederivative. Effect on the motility of vascular endothelial cells 171
Pharmacological inhibition of microsomal prostaglandin e synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis. 171
New tools for the study of cGMP dependent functions: validation in VEGF induced permeability and angiogenesis 171
Angiogenesis 171
Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis 168
Nitric oxide in tumor angiogenesis 166
In vitro and in vivo activation of endothelial cells by colony-stimulating factors 166
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 166
Angiotensin II potentiates the mitogenic effect of noradrenaline in vascular smooth muscle cells via AT1 receptors 165
The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis 165
In vitro and in vivo models to study chemokine regulation of angiogenesis 164
Nitric oxide and angiogenesis 164
Genetic and pharmacological inactivation of cannabinoid CB1 receptor inhibits angiogenesis 161
Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit 161
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk 161
Vimentin expression influences flow dependent VASP phosphorylation and regulates cell migration and proliferation 160
PKCepsilon activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting 159
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo 159
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto chick chorioallantoic membrane: endothelial fenestration and angiogenesis 159
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress 158
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P 158
Nitric oxide releasing metal-diazeniumdiolate complexes strongly induce vasorelaxation and endothelial cell proliferation 156
Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway 156
The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability 155
Repurposing of drugs for triple negative breast cancer: an overview 155
Totale 20.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.366
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.366
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.818 0 0 0 0 0 565 139 647 535 287 312 333
2021/20222.838 187 392 153 349 122 120 133 122 105 327 245 583
2022/20233.805 248 272 497 589 387 778 51 288 406 69 125 95
2023/20242.371 115 50 155 187 62 696 835 56 3 26 16 170
2024/20254.812 88 292 407 301 452 193 95 298 347 216 606 1.517
2025/20267.840 1.022 1.804 1.417 1.218 2.255 124 0 0 0 0 0 0
Totale 36.632